Form 4: Cadre Holdings Director Acquires Stock Options

Cadre Holdings, Inc. Director Nicolas Sokolow acquired stock options, with specific vesting schedules detailed in a Form 4 filing.

Summary

• Nicolas Sokolow, a Director at Cadre Holdings, Inc. (CDRE), has been granted stock options.
• The options are for 17,393 shares of common stock.
• The exercise price for these options is $28.75 per share.
• These options were granted under the Issuer's 2021 Stock Incentive Plan.
• A portion of the options, 4,349 shares, will vest and become exercisable on June 30, 2026.
• Additional tranches of 4,348 shares each will vest and become exercisable on September 30, 2026, December 31, 2026, and March 31, 2027.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard stock option grant to a director with a typical vesting schedule, rather than a significant financial event or performance indicator.

Positives

• Director participation in equity incentives suggests alignment with shareholder interests.
• The grant of stock options indicates a belief in future company growth and stock appreciation.
• The vesting schedule over several years promotes long-term commitment from the director.

Negatives

• The exercise price of $28.75 is higher than the current market price, implying a need for significant stock appreciation to realize value.
• No specific financial performance metrics are tied to this option grant, only time-based vesting.

Risks

• The value of the stock options is directly tied to the future performance of Cadre Holdings' stock price, which is subject to market volatility and company-specific risks.
• If the stock price does not exceed $28.75 per share by the respective vesting dates, the options may not be exercised profitably.
• The vesting schedule, while promoting long-term commitment, also means the director's full benefit from these options is deferred.

Future Outlook

The filing details the vesting schedule for stock options granted to Director Nicolas Sokolow, with portions becoming exercisable between June 30, 2026, and March 31, 2027, and expiring on June 16, 2036. This indicates a long-term incentive structure.

Industry Context

StockSavvy.ai notes that the granting of stock options to directors is a common practice across many industries, including security and defense services, to align executive incentives with shareholder value creation. The specific exercise price and vesting schedule are key details for investors to monitor.

Stakeholder Impact

• Shareholders: The grant of options to a director can be viewed positively as an alignment of interests, but the exercise price being above current market levels means potential dilution or value realization is contingent on future stock performance.
• Management: The director receives a long-term incentive tied to company performance.
• Employees: This filing does not directly impact employees, but it is part of the broader compensation structure of the company.

Next Steps

• Monitor the vesting of the stock options as per the schedule.
• Observe the future trading activity of Nicolas Sokolow related to these options.
• Track Cadre Holdings' stock performance relative to the $28.75 exercise price.

Key Dates

Keywords

Cadre Holdings, CDRE, Form 4, Stock Options, Director, Insider Trading, Equity Incentive Plan, Beneficial Ownership, Vesting Schedule